Australian Alzheimer’s study

Wednesday, 20 June, 2007

A major Australian study to better understand Alzheimer's disease has started.

The $10 million Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing has brought together leading Australian researchers for a three-year study to improve understanding of the causes and diagnosis of the disease, to examine lifestyle and diet factors that may influence the onset of Alzheimer's and to help develop preventative strategies.

It will be one of the world's largest studies of its type involving positron emission tomography (PET) scans using Pittsburgh Compound-B (PIB), a PET amyloid-imaging agent. The scans are used to show differences between the brains of Alzheimer's patients and healthy volunteers.

The study was established by the CSIRO-led Preventative Health National Research Flagship, and involves Edith Cowan University, the University of Melbourne, Neurosciences Australia and the Mental Health Research Institute of Victoria.

Related News

New Albanese ministry urged to advance Aust innovation

Organisations including Cooperative Research Australia, ATSE and the Australian Academy of...

Govt and industry fund health and biotech innovation in SEQ

The SEQ Innovation Economy Fund has awarded eight projects $94m in government funding, while...

Does the 2025–26 Budget do enough for science?

AAMRI has described the 2025–26 federal Budget as "very disappointing" for the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd